| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |